| Dzung Trinh, MD | |
|
347 E Barstow Ave, Ste 102, Fresno, CA 93710-6039 | |
| (559) 550-4344 | |
| (559) 550-6011 |
| Full Name | Dzung Trinh |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 347 E Barstow Ave, Fresno, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679651582 | NPI | - | NPPES |
| 00G652820 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | G65282 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Focus Health | Fresno, CA | Home health agency |
| Ardent Home Health & Palliative Care | Fresno, CA | Home health agency |
| Ardent Hospice & Palliative Care Of Fresno, Inc | Fresno, CA | Hospice |
| Optimal Hospice Care | Fresno, CA | Hospice |
| Saint Agnes Medical Center | Fresno, CA | Hospital |
| Clovis Community Medical Center | Clovis, CA | Hospital |
| Pacific Gardens Nursing And Rehabilitation Center | Fresno, CA | Nursing home |
| The Terraces At San Joaquin Gardens Village | Fresno, CA | Nursing home |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company's strategy to advance its offerings to the molecular diagnostics and research markets.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva's Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development.
The European Society for Medical Oncology just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.
ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.
› Verified 1 days ago
| Entity Name | Regents Of University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659419638 PECOS PAC ID: 7517859994 Enrollment ID: O20040611000997 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company's strategy to advance its offerings to the molecular diagnostics and research markets.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva's Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development.
The European Society for Medical Oncology just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.
ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.
› Verified 1 days ago
| Entity Name | Juventas Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356685101 PECOS PAC ID: 5496989931 Enrollment ID: O20131016000731 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company's strategy to advance its offerings to the molecular diagnostics and research markets.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva's Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development.
The European Society for Medical Oncology just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.
ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.
› Verified 1 days ago
| Entity Name | Dzung Trinh Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366075640 PECOS PAC ID: 8820429095 Enrollment ID: O20200504002613 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company's strategy to advance its offerings to the molecular diagnostics and research markets.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva's Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development.
The European Society for Medical Oncology just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.
ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.
› Verified 1 days ago
| Entity Name | Sven Medical Consulting Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205464906 PECOS PAC ID: 0446660211 Enrollment ID: O20201223002050 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company's strategy to advance its offerings to the molecular diagnostics and research markets.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva's Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development.
The European Society for Medical Oncology just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.
ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.
› Verified 1 days ago
| Entity Name | Twg Medical Cac |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720774466 PECOS PAC ID: 1355701475 Enrollment ID: O20230720000826 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company's strategy to advance its offerings to the molecular diagnostics and research markets.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva's Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development.
The European Society for Medical Oncology just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.
ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dzung Trinh, MD 1090 E Kelso Ave, Fresno, CA 93720-1849 Ph: (559) 906-2962 | Dzung Trinh, MD 347 E Barstow Ave, Ste 102, Fresno, CA 93710-6039 Ph: (559) 550-4344 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company's strategy to advance its offerings to the molecular diagnostics and research markets.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva's Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development.
The European Society for Medical Oncology just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.
ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.
› Verified 1 days ago
Maulik Shah, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 559-448-4555 | |
Rami Alrezk, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 N Fresno St, Fresno, CA 93701 Phone: 559-499-6479 | |
Dr. John R Nelson, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7061 N Whitney, Suite 101, Fresno, CA 93720 Phone: 559-299-0224 Fax: 559-299-4201 | |
Dexter T Estrada, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7130 N Millbrook Ave Ste 100, Fresno, CA 93720 Phone: 559-326-1222 Fax: 559-326-1230 | |
Dr. Sherry Lopez, D.O. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 3209 W Shaw Ave, Suite 114, Fresno, CA 93711 Phone: 559-224-4977 Fax: 559-224-4980 | |
Maria Flordeliz Arambulo, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6484 Fax: 559-499-6501 | |
Shreela Mishra, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7085 N Chestnut Ave Ste 101, Fresno, CA 93720 Phone: 559-323-9236 Fax: 559-323-0294 |